Bacterial meningitis

Infections in Medicine

Volumn 20, Issue 3, 2003, Pages 142-153

  Aronin, Steven I ^a,b   Quagliarello, Vincent J ^b  

^a WATERBURY HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic therapy; Bacterial, meningitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; ISONIAZID; MENINGOCOCCUS VACCINE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PNEUMOCOCCUS VACCINE; PYRAZINAMIDE; RIFAMPICIN; SULFAFURAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

AGE; ANTIBIOTIC THERAPY; ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; BACTERIUM CULTURE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ENTEROBACTERIACEAE; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HUMAN; LISTERIA MONOCYTOGENES; MEDICAL DECISION MAKING; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; PREDICTION; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0037354267     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Tunkel AR, Scheld WM. Acute meningitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000:959-997.
2. Hasbun R. The acute aseptic meningitis syndrome. Curr Infect Dis Rep. 2000;2:345-351.
3. Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination. Does this adult patient have acute meningitis? JAMA. 1999;282:175-181.
4. Thomas K, Hasbun R, Jekel J, Quagliarello VJ. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis. 2002;35:46-52.
5. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862-869.
6. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345:1727-1733.
7. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observation. JAMA. 1989;262:2700-2707.
8. Feigin RD, McCracken GH Jr, Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J. 1992;11:785-814.
9. Greenlee JE. Approach to diagnosis of meningitis. Cerebrospinal fluid evaluation. Infect Dis Clin North Am. 1990;4:583-598.
10. La Scolea LJ Jr, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol. 1984;19:187-190.
11. Coant PN, Kornberg AE, Duffy LC, et al. Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care. 1992;8:200-205.
12. Blazer S, Berant M, Alon U. Bacterial meningitis. Effect of antibiotic treatment on cerebrospinal fluid. Am J Clin Pathol. 1983;80:386-387.
13. Lebel MH, McCracken GH Jr. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989;83:161-167.
14. Sande MA, Korzeniowski OM, Allegro GM, et al. Intermittant or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis. 1981;3:98-109.
15. Short WR, Tunkel AR. Changing epidemiology of bacterial meningitis in the United States. Curr Infect Dis Rep. 2000;2:327-331.
16. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-1924.
17. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997; 337:970-976.
18. Fiore AE, Moroney JF, Farley MM, et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis. 2000;30:71-77.
19. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med. 1997;336:708-716.
20. Aronin SI. Bacterial meningitis: principles and practical aspects of therapy. Curr Infect Dis Rep. 2000;2:337-344.
21. Cabellos C, Martinez-Lacasa J, Martos A, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 1995;39:2158-2160.
22. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother. 1995;39:1988-1992.
23. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. 1997;278: 925-931.
24. Girgis NI, Farid Z, Mikhail IA, et al. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989;8: 848-851.
25. Thomas R, Le Tulzo Y, Bouget J, et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Adult Meningitis Steroid Group. Intensive Care Med. 1999;25:475-480.
26. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549-1556.
27. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53-80.
28. Lieberman JM, Greenberg DP, Ward JI. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis. Infect Dis Clin North Am. 1990;4:703-729.
29. Abramson JS, Spika JS. Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease. J Infect Dis. 1985;151: 370-371.
30. Peltola H. Vaccines against bacterial meningitis. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia: Lippincott-Raven; 1997:1013-1039.
31. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.